vs
Loar Holdings Inc.（LOAR）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
REPLIGEN CORP的季度营收约是Loar Holdings Inc.的1.5倍（$197.9M vs $131.8M），Loar Holdings Inc.净利率更高（9.5% vs 6.7%，领先2.8%），Loar Holdings Inc.同比增速更快（19.3% vs 13.6%），过去两年Loar Holdings Inc.的营收复合增速更高（19.8% vs 14.4%）
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
LOAR vs RGEN — 直观对比
营收规模更大
RGEN
是对方的1.5倍
$131.8M
营收增速更快
LOAR
高出5.6%
13.6%
净利率更高
LOAR
高出2.8%
6.7%
两年增速更快
LOAR
近两年复合增速
14.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $131.8M | $197.9M |
| 净利润 | $12.5M | $13.3M |
| 毛利率 | 52.1% | 52.5% |
| 营业利润率 | 18.0% | 9.0% |
| 净利率 | 9.5% | 6.7% |
| 营收同比 | 19.3% | 13.6% |
| 净利润同比 | 239.5% | 143.9% |
| 每股收益（稀释后） | $0.13 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LOARRGEN
| Q4 25 | $131.8M | $197.9M | ||
| Q3 25 | $126.8M | $188.8M | ||
| Q2 25 | $123.1M | $182.4M | ||
| Q1 25 | $114.7M | $169.2M | ||
| Q4 24 | $110.4M | $174.1M | ||
| Q3 24 | $103.5M | $154.9M | ||
| Q2 24 | $97.0M | $154.1M | ||
| Q1 24 | $91.8M | $151.3M |
净利润LOARRGEN
| Q4 25 | $12.5M | $13.3M | ||
| Q3 25 | $27.6M | $14.9M | ||
| Q2 25 | $16.7M | $14.9M | ||
| Q1 25 | $15.3M | $5.8M | ||
| Q4 24 | $3.7M | $-30.3M | ||
| Q3 24 | $8.7M | $-654.0K | ||
| Q2 24 | $7.6M | $3.3M | ||
| Q1 24 | $2.2M | $2.1M |
毛利率LOARRGEN
| Q4 25 | 52.1% | 52.5% | ||
| Q3 25 | 52.7% | 53.2% | ||
| Q2 25 | 53.8% | 50.0% | ||
| Q1 25 | 52.1% | 53.6% | ||
| Q4 24 | 48.9% | 26.1% | ||
| Q3 24 | 51.1% | 50.0% | ||
| Q2 24 | 49.0% | 49.8% | ||
| Q1 24 | 48.4% | 49.5% |
营业利润率LOARRGEN
| Q4 25 | 18.0% | 9.0% | ||
| Q3 25 | 22.9% | 8.9% | ||
| Q2 25 | 22.2% | 7.6% | ||
| Q1 25 | 22.8% | 3.9% | ||
| Q4 24 | 19.2% | -17.7% | ||
| Q3 24 | 22.1% | -5.1% | ||
| Q2 24 | 22.9% | 1.0% | ||
| Q1 24 | 23.3% | 1.3% |
净利率LOARRGEN
| Q4 25 | 9.5% | 6.7% | ||
| Q3 25 | 21.8% | 7.9% | ||
| Q2 25 | 13.6% | 8.2% | ||
| Q1 25 | 13.4% | 3.4% | ||
| Q4 24 | 3.3% | -17.4% | ||
| Q3 24 | 8.4% | -0.4% | ||
| Q2 24 | 7.9% | 2.2% | ||
| Q1 24 | 2.4% | 1.4% |
每股收益（稀释后）LOARRGEN
| Q4 25 | $0.13 | $0.24 | ||
| Q3 25 | $0.29 | $0.26 | ||
| Q2 25 | $0.17 | $0.26 | ||
| Q1 25 | $0.16 | $0.10 | ||
| Q4 24 | $-11023.48 | $-0.55 | ||
| Q3 24 | $0.09 | $-0.01 | ||
| Q2 24 | $0.09 | $0.06 | ||
| Q1 24 | $11023.54 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $84.8M | $767.6M |
| 总债务越低越好 | $715.7M | $542.2M |
| 股东权益账面价值 | $1.2B | $2.1B |
| 总资产 | $2.0B | $2.9B |
| 负债/权益比越低杠杆越低 | 0.61× | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资LOARRGEN
| Q4 25 | $84.8M | $767.6M | ||
| Q3 25 | $99.0M | $748.7M | ||
| Q2 25 | $103.3M | $708.9M | ||
| Q1 25 | $80.5M | $697.2M | ||
| Q4 24 | $54.1M | $757.4M | ||
| Q3 24 | $55.2M | $784.0M | ||
| Q2 24 | $73.2M | $809.1M | ||
| Q1 24 | $28.2M | $780.6M |
总债务LOARRGEN
| Q4 25 | $715.7M | $542.2M | ||
| Q3 25 | $279.4M | $537.9M | ||
| Q2 25 | $277.7M | — | ||
| Q1 25 | $277.5M | — | ||
| Q4 24 | $277.3M | $525.6M | ||
| Q3 24 | $602.1M | — | ||
| Q2 24 | $250.7M | — | ||
| Q1 24 | $534.2M | — |
股东权益LOARRGEN
| Q4 25 | $1.2B | $2.1B | ||
| Q3 25 | $1.2B | $2.1B | ||
| Q2 25 | $1.1B | $2.1B | ||
| Q1 25 | $1.1B | $2.0B | ||
| Q4 24 | $1.1B | $2.0B | ||
| Q3 24 | $769.8M | $2.0B | ||
| Q2 24 | $758.4M | $2.0B | ||
| Q1 24 | $420.6M | $2.0B |
总资产LOARRGEN
| Q4 25 | $2.0B | $2.9B | ||
| Q3 25 | $1.5B | $2.9B | ||
| Q2 25 | $1.5B | $2.9B | ||
| Q1 25 | $1.5B | $2.9B | ||
| Q4 24 | $1.5B | $2.8B | ||
| Q3 24 | $1.5B | $2.8B | ||
| Q2 24 | $1.1B | $2.9B | ||
| Q1 24 | $1.1B | $2.8B |
负债/权益比LOARRGEN
| Q4 25 | 0.61× | 0.26× | ||
| Q3 25 | 0.24× | 0.26× | ||
| Q2 25 | 0.25× | — | ||
| Q1 25 | 0.25× | — | ||
| Q4 24 | 0.25× | 0.27× | ||
| Q3 24 | 0.78× | — | ||
| Q2 24 | 0.33× | — | ||
| Q1 24 | 1.27× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $30.4M | $25.7M |
| 自由现金流经营现金流 - 资本支出 | — | $17.6M |
| 自由现金流率自由现金流/营收 | — | 8.9% |
| 资本支出强度资本支出/营收 | — | 4.1% |
| 现金转化率经营现金流/净利润 | 2.43× | 1.93× |
| 过去12个月自由现金流最近4个季度 | — | $93.9M |
8季度趋势，按日历期对齐
经营现金流LOARRGEN
| Q4 25 | $30.4M | $25.7M | ||
| Q3 25 | $29.7M | $48.1M | ||
| Q2 25 | $23.8M | $28.6M | ||
| Q1 25 | $28.4M | $15.0M | ||
| Q4 24 | $20.7M | $39.2M | ||
| Q3 24 | $16.3M | $49.3M | ||
| Q2 24 | $7.1M | $42.2M | ||
| Q1 24 | $10.8M | $44.7M |
自由现金流LOARRGEN
| Q4 25 | — | $17.6M | ||
| Q3 25 | — | $43.4M | ||
| Q2 25 | — | $21.5M | ||
| Q1 25 | — | $11.4M | ||
| Q4 24 | — | $33.6M | ||
| Q3 24 | — | $42.3M | ||
| Q2 24 | — | $37.4M | ||
| Q1 24 | — | $36.4M |
自由现金流率LOARRGEN
| Q4 25 | — | 8.9% | ||
| Q3 25 | — | 23.0% | ||
| Q2 25 | — | 11.8% | ||
| Q1 25 | — | 6.8% | ||
| Q4 24 | — | 19.3% | ||
| Q3 24 | — | 27.3% | ||
| Q2 24 | — | 24.3% | ||
| Q1 24 | — | 24.0% |
资本支出强度LOARRGEN
| Q4 25 | — | 4.1% | ||
| Q3 25 | — | 2.5% | ||
| Q2 25 | — | 3.9% | ||
| Q1 25 | — | 2.1% | ||
| Q4 24 | — | 3.2% | ||
| Q3 24 | — | 4.5% | ||
| Q2 24 | — | 3.1% | ||
| Q1 24 | — | 5.5% |
现金转化率LOARRGEN
| Q4 25 | 2.43× | 1.93× | ||
| Q3 25 | 1.08× | 3.23× | ||
| Q2 25 | 1.42× | 1.92× | ||
| Q1 25 | 1.85× | 2.57× | ||
| Q4 24 | 5.62× | — | ||
| Q3 24 | 1.89× | — | ||
| Q2 24 | 0.93× | 12.70× | ||
| Q1 24 | 4.81× | 21.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LOAR
| Other | $76.8M | 58% |
| Commercial Aerospace | $21.2M | 16% |
| Business Jet And General Aviation | $17.6M | 13% |
| Defense | $16.2M | 12% |
RGEN
暂无分部数据
